YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

Novo Nordisk parent pens $16.5B acquisition

Posted online

Danish drugmaker Novo Nordisk's parent company, Novo Holdings, has signed on for a $16.5 billion acquisition.

The company is buying drug manufacturer Catalent.

CNBC reports the deal could help shore up the supply of weight loss injection Wegovy and diabetes shot Ozempic.

Read more from CNBC.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Fall 2026 Architects & Engineers Project Report

This installment of Springfield Business Journal’s Architects & Engineers Project Report showcases 26 endeavors by area design and engineering professionals.

Most Read
Update cookies preferences